Trials / Recruiting
RecruitingNCT06492746
Personal BP - CAI Study
Assessing for Personalized Blood Pressure Targets During Cardiopulmonary Bypass With the Proprietary Cerebral Adaptive Index: A Pilot Investigation
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Edwards Lifesciences · Industry
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
A single-center, prospective, observational pilot of the Cerebral Adaptive Index for assessing personalized blood pressure targets
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HemoSphere Advanced Monitoring Platform with Acumen IQ sensor and Tissue Oximetry Monitoring | The arterial line with Acumen IQ sensor and Foresight Elite sensor will be connected to the HemoSphere monitor with laptop displaying the CAI parameter. |
Timeline
- Start date
- 2024-06-03
- Primary completion
- 2025-11-01
- Completion
- 2025-12-01
- First posted
- 2024-07-09
- Last updated
- 2025-07-14
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06492746. Inclusion in this directory is not an endorsement.